|
| 36993718 | Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer. | bioRxiv | 2024 |
| 37966260 | Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. | Cancer Discov | 2024 |
| 36374194 | OncoLoop: A Network-Based Precision Cancer Medicine Framework. | Cancer Discov | 2023 |
| 37502956 | NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer. | bioRxiv | 2023 |
| 37541213 | Tff2 defines transit-amplifying pancreatic acinar progenitors that lack regenerative potential and are protective against Kras-driven carcinogenesis. | Cell Stem Cell | 2023 |
| 37922910 | Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. | Cancer Cell | 2023 |
| 37024582 | Genomic and transcriptomic analysis of checkpoint blockade response in advanced non-small cell lung cancer. | Nat Genet | 2023 |
| 37116491 | Systematic elucidation and pharmacological targeting of tumor-infiltrating regulatory TÂ cell master regulators. | Cancer Cell | 2023 |
| 37014043 | Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model. | Cancer Res | 2023 |
| 36981431 | NaRnEA: An Information Theoretic Framework for Gene Set Analysis. | Entropy (Basel) | 2023 |
| 37407562 | UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma. | Nat Commun | 2023 |
| 37205498 | Systematic Pan-cancer Functional Inference and Validation of Hyper, Hypo and Neomorphic Mutations. | bioRxiv | 2023 |
| 37268690 | Therapeutic blood-brain barrier modulation and stroke treatment by a bioengineered FZD<sub>4</sub>-selective WNT surrogate in mice. | Nat Commun | 2023 |
| 37061969 | A Transcriptome-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies. | Cancer Discov | 2023 |
| 36585452 | Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer. | Nat Cancer | 2023 |
| 36824919 | Network-based elucidation of colon cancer drug resistance by phosphoproteomic time-series analysis. | bioRxiv | 2023 |
| 34728525 | A Phase II Study of the Efficacy and Safety of Oral Selinexor in Recurrent Glioblastoma. | Clin Cancer Res | 2022 |
| 35843032 | Non-urothelial lesions of the urinary bladder A 14.5-year, single-institution review. | Pathol Res Pract | 2022 |
| 35478225 | A multi-organ chip with matured tissue niches linked by vascular flow. | Nat Biomed Eng | 2022 |
| 35854100 | A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection. | Commun Biol | 2022 |
| 36195086 | Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors. | Med | 2022 |
| 36083100 | A Patient-to-Model-to-Patient (PMP) Cancer Drug Discovery Protocol for Identifying and Validating Therapeutic Agents Targeting Tumor Regulatory Architecture. | Curr Protoc | 2022 |
| 35132404 | A Model for Network-Based Identification and Pharmacological Targeting of Aberrant, Replication-Permissive Transcriptional Programs Induced by Viral Infection. | Res Sq | 2022 |
| 35319286 | Adult enteric Dclk1-positive glial and neuronal cells reveal distinct responses to acute intestinal injury. | Am J Physiol Gastrointest Liver Physiol | 2022 |
| 34965795 | The best prostate biopsy sampling system-fusion and systematic biopsy: A single center experience. | Urologia | 2022 |
| 35262677 | Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer. | Clin Cancer Res | 2022 |
| 35106508 | A community challenge for a pancancer drug mechanism of action inference from perturbational profile data. | Cell Rep Med | 2022 |
| 35167496 | Notch-mediated Ephrin signaling disrupts islet architecture and β cell function. | JCI Insight | 2022 |
| 32929263 | Oncoprotein-specific molecular interaction maps (SigMaps) for cancer network analyses. | Nat Biotechnol | 2021 |
| 33829464 | SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy. | Eur Rev Med Pharmacol Sci | 2021 |
| 33637604 | Longitudinal Immune Profiling Reveals Unique Myeloid and T-cell Phenotypes Associated with Spontaneous Immunoediting in a Prostate Tumor Model. | Cancer Immunol Res | 2021 |
| 33930309 | Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. | Cancer Cell | 2021 |
| 34907913 | BACH2 inhibition reverses β cell failure in type 2 diabetes models. | J Clin Invest | 2021 |
| 34753775 | HER3 Is an Actionable Target in Advanced Prostate Cancer. | Cancer Res | 2021 |
| 34019793 | Single-cell protein activity analysis identifies recurrence-associated renal tumor macrophages. | Cell | 2021 |
| 34129825 | Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. | Cancer Cell | 2021 |
| 34323164 | A 2:1 randomized, open-label, phase II study of selinexor vs. physician's choice in older patients with relapsed or refractory acute myeloid leukemia. | Leuk Lymphoma | 2021 |
| 34341990 | Fimepinostat (CUDC-907) in patients with relapsed/refractory diffuse large B cell and high-grade B-cell lymphoma: report of a phase 2 trial and exploratory biomarker analyses. | Br J Haematol | 2021 |
| 34169393 | Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer. | Breast Cancer Res Treat | 2021 |
| 34108263 | Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways. | Mol Cancer Ther | 2021 |
| 33434495 | A modular master regulator landscape controls cancer transcriptional identity. | Cell | 2021 |
| 33451982 | A CRISPR/Cas9-Engineered <i>ARID1A</i>-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation. | Cancer Discov | 2021 |
| 32945242 | Massive intra-abdominal recurrence after robotic-assisted radical cystectomy: A case report and critical appraisal of literature. | Urologia | 2021 |
| 32511361 | The Host Cell ViroCheckpoint: Identification and Pharmacologic Targeting of Novel Mechanistic Determinants of Coronavirus-Mediated Hijacked Cell States. | bioRxiv | 2020 |
| 33490923 | Prioritizing transcriptional factors in gene regulatory networks with PageRank. | iScience | 2020 |
| 31959337 | A meta-analysis of the accuracy of a neuroendocrine tumor mRNA genomic biomarker (NETest) in blood. | Ann Oncol | 2020 |
| 31852831 | Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma. | Clin Cancer Res | 2020 |
| 33333029 | SECAT: Quantifying Protein Complex Dynamics across Cell States by Network-Centric Analysis of SEC-SWATH-MS Profiles. | Cell Syst | 2020 |
| 33354662 | <i>N</i>-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB. | iScience | 2020 |
| 33296649 | The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State. | Cell Rep | 2020 |